Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.

Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Total published articles

22 58 59 65 23 13 36 34 49 63 101 62 44 26

Research, Review articles and Editorials

2 4 1 2 12 12 29 28 44 56 80 48 12 19

Research communications, Review communications, Editorial communications, Case reports and Commentary

20 54 58 63 11 1 7 6 5 7 21 14 32 6

Conference proceedings

0 40 12 37 0 0 145 138 95 63 154 72 54 0

Citations received as per Google Scholar, other indexing platforms and portals

522 678 761 838 697 626 613 599 538 478 262 142 31 69
Journal total citations count 6793
Journal impact factor 1.64
Journal 5 years impact factor 1.70
Journal cite score 11.56
Journal h-index 33
Important citations

Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial

Engineering precision therapies: lessons and motivations from the clinic

Genome writing: current progress and related applications

Gene therapy for X-linked severe combined immunodeficiency: historical outcomes and current status

Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice

Next generation sequencing in newborn screening in the United Kingdom National Health Service

Advances and highlights in primary immunodeficiencies in 2017

Thymus autonomy as a prelude to leukemia

Gene therapy using haematopoietic stem and progenitor cells

T cell acute lymphoblastic leukemia as a consequence of thymus autonomy

Gene therapy and genome editing for primary immunodeficiency diseases

CRISPR/Cas9-modified hematopoietic stem cells—present and future perspectives for stem cell transplantation

From stem cells to functional lymphocytes: cell differentiation and gene therapy implementation for RAG-SCID

Illuminating the genome-wide activity of genome editors for safe and effective therapeutics

Defining B cell tolerance checkpoints and their modulation by immunotherapy

Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott-Aldrich Syndrome

 Answered and Unanswered Questions in Early-Stage Viral Vector Transduction Biology and Innate Primary Cell Toxicity for Ex-Vivo Gene Editing

CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich's

Self-renewal of double-negative 3 early thymocytes enables thymus autonomy but compromises the ?-selection checkpoint

p53 and Cell Fate: Sensitizing Head and Neck Cancer Stem Cells to Chemotherapy